BIOSCRIPT STIRLING LIMITED

Active Macclesfield

Management consultancy activities other than financial management

98 employees website.com
Life sciences and medical technology Management consultancy activities other than financial management
B

BIOSCRIPT STIRLING LIMITED

Management consultancy activities other than financial management

Founded 17 Jan 2002 Active Macclesfield, England 98 employees website.com
Life sciences and medical technology Management consultancy activities other than financial management

Previous Company Names

STIRLINGWORD LIMITED 5 Feb 2002 — 15 Feb 2007
HAJCO 240 LIMITED 17 Jan 2002 — 5 Feb 2002
Accounts Submitted 27 Jun 2025 Next due 30 Jun 2026 2 months remaining
Confirmation Submitted 5 Feb 2026 Next due 6 Feb 2027 9 months remaining
Net assets £9M £3M 2024 year on year
Total assets £18M £7M 2024 year on year
Total Liabilities £9M £4M 2024 year on year
Charges 2
2 outstanding

Contact & Details

Contact

Registered Address

Suite A, Greenway House Larkwood Way Tytherington Business Park Macclesfield SK10 2XR England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for BIOSCRIPT STIRLING LIMITED (04354625), an active life sciences and medical technology company based in Macclesfield, England. Incorporated 17 Jan 2002. Management consultancy activities other than financial management. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2013–2024)

Cash in Bank

£808.50k

Increased by £376.28k (+87%)

Net Assets

£8.82M

Increased by £3.02M (+52%)

Total Liabilities

£9.13M

Increased by £3.75M (+70%)

Turnover

£11.93M

Increased by £914.24k (+8%)

Employees

98

Decreased by 2 (-2%)

Debt Ratio

51%

Increased by 3 (+6%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Gabrielle Alison SilverDirectorBritishEngland5215 Feb 2024Active
James MaxwellDirectorBritishUnited Kingdom4115 Feb 2024Active

Shareholders

Shareholders (1)

Bioscript Group Limited
100.0%
39,474

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 17 Jan 2017
Nature of Control
  • Voting Rights 75 To 100 Percent

Group Structure

Group Structure

BB SHELF 4 LLP united kingdom
BIOSCRIPT LIMITED united kingdom
BIOSCRIPT STIRLING LIMITED Current Company

Charges

Charges

2 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
6 Feb 2026Persons With Significant ControlChange to Bioscript Group Limited as a person with significant control on 2017-01-17
5 Feb 2026Confirmation StatementConfirmation statement made on 2026-01-23 with no updates
27 Jun 2025AccountsAnnual accounts made up to 2024-09-30
7 Feb 2025OfficersChange to director Mr James Maxwell on 2025-02-06
6 Feb 2025Confirmation StatementConfirmation statement made on 2025-01-23 with updates
6 Feb 2026 Persons With Significant Control

Change to Bioscript Group Limited as a person with significant control on 2017-01-17

5 Feb 2026 Confirmation Statement

Confirmation statement made on 2026-01-23 with no updates

27 Jun 2025 Accounts

Annual accounts made up to 2024-09-30

7 Feb 2025 Officers

Change to director Mr James Maxwell on 2025-02-06

6 Feb 2025 Confirmation Statement

Confirmation statement made on 2025-01-23 with updates

Recent Activity

Latest Activity

Change to Bioscript Group Limited as a person with significant control on 2017-01-17

2 months ago on 6 Feb 2026

Confirmation statement made on 2026-01-23 with no updates

2 months ago on 5 Feb 2026

Annual accounts made up to 2024-09-30

10 months ago on 27 Jun 2025

Change to director Mr James Maxwell on 2025-02-06

1 years ago on 7 Feb 2025

Confirmation statement made on 2025-01-23 with updates

1 years ago on 6 Feb 2025